Bavarian Nordic A/S EBIT

The latest EBIT for BVNKF is $1.9B as of June 2026. That compares with $1.5B in the prior-year period — up 30.0% year over year. That is below the Healthcare sector average of $99B. Investors often review this figure alongside Bavarian Nordic A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, BVNKF's EBIT moved from $1.5B to $1.9B — a 30.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bavarian Nordic A/S's operating scale or balance-sheet position.

Against Healthcare companies, BVNKF currently prints $1.9B for EBIT, while the sector average sits near $99B. That is roughly 98.1% below the sector mean. Large gaps often invite a closer look at Bavarian Nordic A/S's growth, margins, and balance sheet.

A EBIT figure of $1.9B for BVNKF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $99B. Explore the charts below for those layers of context.

After noting BVNKF's EBIT ($1.9B), review year-over-year change from $1.5B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.